Cardiac transplantation: treatment for cardiogenic shock.
Eighty-six patients received orthotopic cardiac transplants at the Royal Victoria Hospital in Montreal between 1985 and 1989. Of these, 16 mortally ill, being sustained in hospital by the intravenous administration of inotropic agents (15 patients [94%]) or intra-aortic balloon counterpulsation (6 [38%]). There was one early death (at 7 days), for a death rate of 6.3% (versus 8.6% for the 70 "elective" transplants). Two others died of delayed infection: one of viral hepatitis at 6 weeks, and one of pneumonia due to Pneumocystis 4 months after transplantation. The other 13 patients are alive and well 12 to 66 months postoperatively. Nine have returned to their preoperative work, three have decreased activity levels but are functioning well, and one is retired.
Jackson
S J
SJ
Cardiovascular Research Unit, Royal Victoria Hospital, Montreal, Que.
Dobell
A R
AR
Poirier
N
N
Guerraty
A J
AJ
Symes
J F
JF
D000328:Adult; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000401:mortality / Q000534:rehabilitation; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012770:Shock, Cardiogenic / Q000601:surgery*